Evidence map›Paper›PMID 40866513›Full record

ArticleNature cell biology2025

Synthetic ZFTA fusions pinpoint disordered protein domain acquisition as a mechanism of brain tumorigenesis.

A Arabzade, H K Shirnekhi, S Varadharajan, S M Ippagunta, A H Phillips, N Laboe, D W Baggett, Wahiduzzaman, M Jo, T Zheng and 41 more

Abstract read
In one paragraph

Article in Nature cell biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. ZFTA::YAP1-rearranged ependymoma: is still ZFTA or already YAP?Acta neuropathologica communications · 2026
    Article
  5. Article
  6. Testicular mRNA-LNP Delivery: A Novel Therapy for Genetic Spermatogenic Disorders.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

51 authors.

A Arabzade *Department of Chemical and Biomolecular Engineering, Rice University, Houston, TX, USA.
H K Shirnekhi *Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
S Varadharajan *Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0002-2033-0758
S M Ippagunta *Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
A H PhillipsDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
N LaboeDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
D W BaggettDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
WahiduzzamanDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
M JoDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
T ZhengDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0003-3385-7353
R PathakDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
D GeeDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
D BhimsariaIndian Institute of Technology, Roorkee, India.
H WuDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA.
X GaoDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
J LiuDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
E EmanusDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
A BlandDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
A KardianDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
A HancockDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
B HolcombDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
T WrightDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
T BugbeeDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
H SunDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
M ZhaiDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0009-0005-4694-2823
E CaesarDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
M ParkDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
S TripathiCenter of Excellence in Neuro-Oncology Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
A ShirinifardDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
K LoweDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
A KhalighifarDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
R A PetersenDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0001-6960-2948
S KingDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
D StableyDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
A PitreCell and Tissue Imaging Center - Light Microscopy, St. Jude Children's Research Hospital, Memphis, TN, USA.
G E CampbellCell and Tissue Imaging Center - Light Microscopy, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0003-1288-2576
C-G ParkDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
W T FreyaldenhovenDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
B ChandraDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Y XiaDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
E BontenDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.
A AchariDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.
S KandikondaDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.
A CariseyCenter for Pediatric Neurological Disease Research, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0003-1326-2205
S B PoundsDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA.
J XuDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0003-1988-7337
D W EllisonDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
B DeneenCancer and Cell Biology Program, Baylor College of Medicine, Houston, TX, USA.ORCID http://orcid.org/0000-0002-6335-1081
K C BertrandNeurobiology and Brain Tumor Program, St. Jude Children's Research Hospital, Memphis, TN, USA.
R W KriwackiDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA. richard.kriwacki@stjude.org.ORCID http://orcid.org/0000-0002-9798-6018
S C MackDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA. stephen.mack@stjude.org.ORCID http://orcid.org/0000-0001-9620-4742

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GERARD PAUL ZAMBETTI · 1985 to 2026
$166.9M
Project 4U54CA243124 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI MULLIGHAN, CHARLES G. · 2019 to 2023
$10.5M
LAMPSP01CA298963 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI RICHARD W KRIWACKI, Charles G Mullighan · 2025 to 2026
$9.1M
Synthetic molecules to stimulate the expression of Frataxin to ameliorate Freidreichs AtaxinR01NS108376 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI ASEEM Z ANSARI · 2018 to 2026
$3.6M
Role of Phase separation by fusion oncoproteins in oncogenesisR01CA246125 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI DENIZ, ASHOK A, KRIWACKI, RICHARD W · 2020 to 2024
$3.2M
Targeting tumor and T cell DNA methylomes to improve CAR T cell therapies for diffuse midline gliomaU01CA281823 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Giedre Krenciute, Stephen C Mack · 2023 to 2026
$2.8M
Role of FACT in ZFTA-RelA fusion driven ependymomaR01CA280203 · NCI · OHIO STATE UNIVERSITY · PI Stephen C Mack, Monica Venere · 2023 to 2026
$2.8M
Deciphering the Role of Aberrant Endogenous Retroviral Expression in Onco-histone Driven GliomaR01NS116361 · NINDS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Stephen C Mack · 2021 to 2026
$2.5M
Transcriptional Regulation in ZFTA-RELA EpendymomaR01CA284455 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Benjamin Deneen, Stephen C Mack · 2023 to 2026
$2.5M
Discovering the mechanisms underlying oncogenesis by ZFTA-RELA and pinpointing therapeutic targets.U01CA294103 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI RICHARD W KRIWACKI, Stephen C Mack · 2024 to 2026
$1.7M
Revealing Masked Specificities of Human Nuclear ReceptorsR01GM120625 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI ANSARI, ASEEM Z · 2016 to 2019
$1.7M
Alex's Lemonade Stand Foundation for Childhood Cancer (Alex's Lemonade Stand Foundation) A Award (Mack)American Lebanese Syrian Associated Charities (ALSAC) (Mack)National Brain Tumor Society (National Brain Tumor Society, Inc.) (Mack)NCI NIH HHS P01 CA298963NCI NIH HHS P30 CA021765NCI NIH HHS R01 CA246125NCI NIH HHS R01 CA280203NCI NIH HHS R01 CA284455NCI NIH HHS U01 CA281823NCI NIH HHS U01 CA294103NCI NIH HHS U54 CA243124NIGMS NIH HHS R01 GM120625NINDS NIH HHS R01 NS108376NINDS NIH HHS R01 NS116361U.S. Department of Defense (United States Department of Defense) CA220247U.S. Department of Defense (United States Department of Defense) CA220510U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA246125U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA280203U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA284455U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) U01CA281823U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) U01CA294103U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) U54CA243124U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01NS128184
6 · The paper itself

Abstract

Over 95% of ependymomas that arise in the cortex are driven by a gene fusion involving the zinc finger translocation-associated (ZFTA) protein. Here, using super-resolution and lattice light-sheet microscopy, we demonstrate that the most frequent fusion variant, ZFTA-RELA (ZR), forms dynamic nuclear condensates that are required for oncogene expression and tumorigenesis. Mutagenesis studies of ZR reveal a key intrinsically disordered region (IDR) in RELA that governs condensate formation. Condensate-modulating IDR mutations introduced into ZR impaired its genomic occupancy at oncogenic loci and inhibited the recruitment of transcriptional effector proteins, such as MED1, BRD4 and RNA polymerase II. Using nuclear magnetic resonance spectroscopy, we examined the DNA-binding residues of the critical zinc finger (ZF1) found in ZR and characterized their significance for condensate formation, genomic binding and oncogene activation. We generated synthetic ZFTA fusion proteins where IDRs from known condensate-forming proteins were grafted into ZR. Synthetic ZFTA fusion oncoproteins utilizing IDRs from EWS and FUS restored condensate formation, oncogene transcription and tumour initiation in mice. These findings provide key insights into the oncogenic mechanism of ZR and the importance of IDR acquisition in fusion oncoproteins in brain cancer.

Indexed as

Brain NeoplasmsCarcinogenesisIntrinsically Disordered ProteinsOncogene Proteins, FusionTranscription Factor RelAZinc FingersAnimalsCell Line, TumorGene Expression Regulation, NeoplasticHumansMiceProtein DomainsRNA-Binding Protein EWSRNA-Binding Protein FUSTranscription FactorsIntrinsically Disordered ProteinsOncogene Proteins, FusionRNA-Binding Protein EWSRNA-Binding Protein FUSTranscription Factor RelATranscription Factors

Identifiers

PMID40866513
PMCPMC12431856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.